The PZIR clinical study group comprised clinicians who investigated protamine zinc recombinant human insulin for the purpose of obtaining FDA approval for treatment of cats with diabetes mellitus. In addition to Drs Nelson, Henley, and Cole, other veterinarian members of the group were Kevin Barcus, Noemi Benitah, Marc Bercovitch, Adrianne Brode, Cheryl Burke, Bonnie Cate, Marcia Chastain, Jeff Dennis, Gary Edlin, Deborah Edwards, Scott Linick, Harrison Monk, Jean Pitcarin, James Prueter, Michelle Purnell, Michael Radcliffe, Roger Sifferman, and Jennifer Usiak.
Field Safety and Efficacy of Protamine Zinc Recombinant Human Insulin for Treatment of Diabetes Mellitus in Cats
Article first published online: 26 JUN 2009
Copyright © 2009 by the American College of Veterinary Internal Medicine
Journal of Veterinary Internal Medicine
Volume 23, Issue 4, pages 787–793, July/August 2009
How to Cite
Nelson, R.W., Henley, K., Cole, C. and the PZIR Clinical Study Group (2009), Field Safety and Efficacy of Protamine Zinc Recombinant Human Insulin for Treatment of Diabetes Mellitus in Cats. Journal of Veterinary Internal Medicine, 23: 787–793. doi: 10.1111/j.1939-1676.2009.0342.x
- Issue published online: 26 JUN 2009
- Article first published online: 26 JUN 2009
- Submitted July 30, 2008; Revised April 30, 2009; Accepted May 04, 2009.
- 2Diabetes mellitus in the cat. J Am Anim Hosp Assoc 1973;9:548–554.